Usd/chf mid-day outlook

Daily Pivots: (S1) 0.9802; (P) 0.9838; (R1) 0.9876; More… USD/CHF’s fall from 1.0146 accelerates lo...

November 10, 2022, 2:22 pm

Usd/chf daily outlook

Daily Pivots: (S1) 0.9802; (P) 0.9838; (R1) 0.9876; More… Intraday bias in USD/CHF remains on the dow...

November 10, 2022, 7:22 am

Goldman sachs stay bearish gbp, further downside ahead vs. eur and usd

This is via the folks at eFX.

For bank trade ideas, ...

November 9, 2022, 9:34 pm

Goldman sachs on the 'bleak picture' for europe & more on why they cut eur/usd forecast

This is via the folks at eFX.

For bank trade ideas, ...

November 8, 2022, 10:03 pm

Hilton grand vacations slides on q4 earnings miss

Hilton Grand Vacations Inc (NYSE: HGV) reported fourth-quarter FY21 revenues of $838 million, missing ...

March 1, 2022, 3:42 pm

Hilton grand vacations slides on q4 earnings miss

Hilton Grand Vacations Inc (NYSE: HGV) reported fourth-quarter FY21 revenues of $838 million, missing ...

March 1, 2022, 3:42 pm

Hilton grand vacations slides on q4 earnings miss

Hilton Grand Vacations Inc (NYSE: HGV) reported fourth-quarter FY21 revenues of $838 million, missing ...

March 1, 2022, 3:42 pm

Immunic, inc. to present preclinical data for vidofludimus calcium at the 17th congress of european crohn's and colitis organization and announces blinded baseline characteristics of its phase 2 caldo

NEW YORK, Feb. 18, 2022 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective ...

February 18, 2022, 6:30 am

Immunic, inc. to present preclinical data for vidofludimus calcium at the 17th congress of european crohn's and colitis organization and announces blinded baseline characteristics of its phase 2 caldo

NEW YORK, Feb. 18, 2022 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective ...

February 18, 2022, 6:30 am

Immunic, inc. to present preclinical data for vidofludimus calcium at the 17th congress of european crohn's and colitis organization and announces blinded baseline characteristics of its phase 2 caldo

NEW YORK, Feb. 18, 2022 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective ...

February 18, 2022, 6:30 am

Booking holdings stock (bkng): $2,838 price target from ubs

The shares of Booking Holdings Inc (NASDAQ: BKNG) have received a price target of $2,838. These are the...

December 5, 2021, 10:02 pm

Booking holdings stock (bkng): $2,838 price target from ubs

The shares of Booking Holdings Inc (NASDAQ: BKNG) have received a price target of $2,838. These are the...

December 5, 2021, 10:02 pm

Booking holdings stock (bkng): $2,838 price target from ubs

The shares of Booking Holdings Inc (NASDAQ: BKNG) have received a price target of $2,838. These are the...

December 5, 2021, 10:02 pm

National bank holdings corporation announces date for 2021 third quarter earnings release

DENVER, Oct. 08, 2021 (GLOBE NEWSWIRE) -- National Bank Holdings Corporation (NYSE: NBHC) expects to report its third quarter financial results after ...

October 8, 2021, 4:36 pm

National bank holdings corporation announces date for 2021 third quarter earnings release

DENVER, Oct. 08, 2021 (GLOBE NEWSWIRE) -- National Bank Holdings Corporation (NYSE: NBHC) expects to report its third quarter financial results after ...

October 8, 2021, 4:36 pm

National bank holdings corporation announces date for 2021 third quarter earnings release

DENVER, Oct. 08, 2021 (GLOBE NEWSWIRE) -- National Bank Holdings Corporation (NYSE: NBHC) expects to report its third quarter financial results after ...

October 8, 2021, 4:36 pm

Cidara therapeutics announces pricing of concurrent public offerings of common stock and preferred stock

SAN DIEGO, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics des...

October 8, 2021, 9:12 am

Cidara therapeutics announces pricing of concurrent public offerings of common stock and preferred stock

SAN DIEGO, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics des...

October 8, 2021, 9:12 am

Cidara therapeutics announces pricing of concurrent public offerings of common stock and preferred stock

SAN DIEGO, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics des...

October 8, 2021, 9:12 am